HiLo - Pragmatic trial of higher vs. lower serum phosphate targets in patients undergoing hemodialysis (UH3 phase)

Dr. Isakova, PI of subcontract, will continue to work closely with Dr. Wolf, the PI of Hilo, during both phases of the award. She will contribute to protocol and consent development, optimization of the intervention strategy, IRB document preparation, training of nutritionists of dialysis sites and monitoring of fidelity of the intervention. Dr. Isakova will join all HiLo calls, attend in-person meetings and contribute to the development and conduct of the study.